Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04556786 · ClinicalTrials.gov registry record · NA

A Pharmacist-led Transitions of Care Program

A NA study of Chronic Disease, sponsored by Auburn University.

Completed
Registry status
NA
Development phase
88
Enrollment target
1
Study location

NCT04556786 is a NA study of Chronic Disease that has completed, run by Auburn University. The registered enrollment target is 88 participants, below the 89,941-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04556786, a NA study of Chronic Disease, has completed, sponsored by Auburn University.

COMPLETED
Registry status
NA
Development phase
88 participants
Enrollment target
1
Study location

Study Summary

This study was to show the value of pharmacists in providing transitions of care to and improving health outcomes of uninsured populations. It also aimed to demonstrate the feasibility of implementing a transitions of care program in an indigent care clinic with limited resources. We hypothesized that a pharmacist-led transitions of care program will reduce 30-day hospital readmission rates among the uninsured discharged from a community hospital.

Conditions Studied

Interventions

  • BEHAVIORAL Transitions of care

Study Locations (1)

Alabama

  • Mercy Medical Clinic - Auburn

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2018-10-02
Est. Completion 2019-07-16
Phase NA

Sponsor

Auburn University

54 total trials

What the Registry Record Tells You About NCT04556786

The ClinicalTrials.gov registry entry for NCT04556786 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 89,941-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower). The listed sponsor is Auburn University, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Disease appearing as the primary indexed condition, and to 1 intervention - of which Transitions of care is the first listed.

NCT04556786 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT04556786 about?

NCT04556786 is a clinical study titled "A Pharmacist-led Transitions of Care Program". This study was to show the value of pharmacists in providing transitions of care to and improving health outcomes of uninsured populations. It also aimed to demonstrate the feasibility of implementing a transitions of care program in an indigent care clinic with limited resources. We hypothesized th...

What is the current status of trial NCT04556786?

This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2018-10-02. Estimated completion is 2019-07-16.

What conditions does trial NCT04556786 study?

This clinical trial studies the following conditions: Chronic Disease.

What interventions are being tested in trial NCT04556786?

The interventions under investigation include: Transitions of care (BEHAVIORAL).

Who is sponsoring clinical trial NCT04556786?

This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04556786 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.